E. Carillon, La phytothérapie face à l'évolution médicale, pp.10-15, 2000.

, Organisation Mondiale de la Santé, Directives OMS sur les bonnes pratiques agricoles et de récolte (BPAR) relatives aux plantes médicinales, 2003.

G. N. Zirihi, A. K. Kra, and F. Guédé-guina, Evaluation de l'activité antifongique de Microglossa pyrifolia (Larmarck) O. kuntze (Asteraceae) pymi sur la croissance in vitro de Candida albicans, Rev Med Pharmacol Afr, vol.17, issue.3, pp.11-19, 2003.

, PROTA (Plant Resources of Tropical Africa / Ressources végétales de l'Afrique tropicale), 2006.

J. P. Guissou, K. H. Millogo, and I. Z. Kaboré, Etude comparative de l'activité pharmacologique d'Euphorbia hirta L. (Euphorbiaceae) et Holarrhena floribunda G. Don (Apocynaceae) vis à vis des amibes non pathogènes du gène amoeba proteus, Méd. Afr, vol.39, issue.5, pp.359-363, 1992.

B. Bayala, H. H. Tamboura, M. R. Pellicer, D. Zongo, A. Traoré et al., Effets oestrogéniques du macéré aqueux des feuilles de Holarrhena floribunda (G. Don) Dur & Schinz chez la rate ovariectomisée. Biotechnologie, agronomie, société et environnement, vol.10, pp.61-64, 2006.

J. A. Badmus, O. A. Odunola, E. M. Obuotor, and O. O. Oyedapo, Phytochemicals and in vitro antioxidant potentials of defatted methanolic extract of Holarrhena floribunda leaves, Afr. J. Biotech, vol.9, issue.3, pp.34-346, 2010.

M. Leboeuf, A. Cave, R. Goutarel, and . Steroid-alkaloids, Presence of Progesterone in the Leaves of Holarrhena Floribunda (G. Don) Duer. And Schinz, Hebd. Seances. Acad. Sci, vol.259, pp.3401-3403, 1964.

R. D. Bennett and E. Heftmann, Progesterone: biosynthesis from pregnenolone in Holarrhena floribunda, Science, vol.149, issue.3684, pp.652-655, 1965.

B. N. Gnangoran, . Bb, P. Amoateng, K. Dosso, A. P. Yapo et al., Hypoglycaemic activity of ethanolic leaf extract and fractions of Holarrhena floribunda (Apocynaceae), Journal of Medical and Biomedical Sciences, vol.1, issue.3, pp.46-54, 2012.

A. Khattabi, N. Rhalem, A. Chabat, S. Skali, S. Bencheich et al., Plants toxiques: definition et classification, Toxicology Maroc, vol.2, pp.3-4, 2010.

, Organization of Economic Co-operation and Development (OECD), 1998.

W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clinical chemistry, vol.18, issue.6, pp.499-502, 1972.

J. A. Timbrell, Principles of biochemical toxicology, pp.76-77, 2008.

J. Bryant, J. Picot, L. Baxter, G. Levitt, I. Sullivan et al., Use of cardiac markers to assess the toxic effects of Anthracyclines given to children with cancer: a systematic review, European journal of cancer, vol.43, issue.13, pp.1959-66, 2007.

D. N. Lobo and . Fluid, electrolytes and nutrition: physiological and clinical aspects, Proceedings of the Nutrition Society, vol.63, pp.453-66, 2004.

A. Bogarapu-kiranmayi, R. Lakshmi, C. Tagore, and . Kambar, Evaluation of Cardiac Markers in Chronic Renal Failure, Journal of Dental and Medical Sciences, vol.14, issue.1, pp.46-52, 2015.

N. El-sherif and G. Turitto, Electrolyte disorders and arrhythmogenesis, Cardiol J, 2011.

O. E. Osadchii, Mechanisms of hypokalemia-induced ventricular arrhythmogenicity. Fundamental & clinical pharmacology, vol.24, pp.547-59, 2010.

C. A. Remme and C. R. Bezzina, Review: sodium channel (dys) function and cardiac arrhythmias. Cardiovascular therapeutics, 2010.

J. Beaudeux, D. Louis, and . Geneviève, Biochimie médicale marqueurs actuels et perspectives, 2 ème édition, Edition Lavoisier MSP, p.607, 2011.

A. Fiacre, E. Plouvier, and A. Vincent, Les examens de laboratoire, vol.324, 2002.

L. Filho, H. G. Ferreira, N. L. Sousa, R. B. Carvalho, E. R. Lobo et al., Experimental model of myocardial infarction induced by isoproterenol in rats, Brazilian Journal of Cardiovascular Surgery, vol.26, issue.3, pp.469-76, 2011.

P. Dieusaert, Guide pratiques des analyses de laboratoire. Edition Maloine-Paris, p.1453, 2005.

H. Jeremy and J. Ashley, Bilan biochimique Edition Elsevier/Masson, p.229, 2009.

E. N. Sock, I. Cote, J. S. Mentor, D. Prudhomme, R. Bergeron et al., Ovariectomy stimulates hepatic fat and cholesterol accumulation in high-fat diet-fed rats. Hormone and Metabolic Research, vol.45, pp.283-90, 2013.

R. R. Paris and A. Foucaud, Flavonoids in the leaves of Holarrhena floribunda G. Don (Durand and Schinz): isolation of a flavonoside identified as isoquercitroside. Comptes rendus hebdomadaires des seances de l'Academie des sciences, vol.248, pp.2634-2635, 1959.

, Rapport sur la médecine traditionnelle et ses implications éthiques, 2010.

, Stratégie de l'OMS pour la médecine traditionnelle pour, 2013.

G. H. Schmelzer, (. G. Holarrhena-floribunda, ). T. Don, . Durand, and . Schinz, PROTA (Plant Resources of Tropical Africa / Ressources végétales de l'Afrique tropicale), 2006.

J. P. Guissou, K. H. Millogo, and I. Z. Kaboré, Etude comparative de l'activité pharmacologique d'Euphorbia hirta L. (Euphorbiaceae) et Holarrhena floribunda G. Don (Apocynaceae) vis à vis des amibes non pathogènes du gène amoeba proteus, Méd. Afr, vol.39, issue.5, pp.59-363, 1992.

B. Balé, H. Tamboura, R. Pellicer, D. Zongo, A. Traoré et al., Effets oestrogéniques du macéré aqueux des feuilles de Holarrhena floribunda (G. Don) Dur. And Schinz chez la rate ovariectomisée, Biotechnol. Agron. Soc. Environ, vol.10, issue.3, pp.61-64, 2006.

J. A. Badmus, O. A. Odunola, E. M. Obuotor, and O. O. Oyedapo, Phytochemicals and in vitro antioxidant potentials of defatted methanolic extract of Holarrhena floribunda leaves, Afr. J. Biotech, vol.9, issue.3, pp.34-346, 2010.

M. Leboeuf, A. Cave, R. Goutarel, and . Steroid-alkaloids, Presence of Progesterone in the Leaves of Holarrhena Floribunda (G. Don) Durand. And Schinz, Hebd. Seances. Acad. Sci, vol.259, pp.3401-3403, 1964.

R. D. Bennett and E. Heftmann, Progesterone: biosynthesis from pregnenolone in Holarrhena floribunda, Science, vol.149, issue.3684, pp.652-655, 1965.

B. N. Gnangoran, . Bb, P. Amoateng, K. Dosso, A. Yapo et al., Hyperglycaemic activity of ethanolic leaf extract and fraction of Holarrhena floribunda (G. Don) Durand & Schinz Apocynaceae, Journal of Medical and Biomedical Sciences, vol.1, issue.13, pp.46-54, 2012.

D. D. Koudou, I. O. Tra-bi, J. B. Oussou, M. Kone, A. P. Yapo et al., Cardiac Tolerance of An Ethyl Acetate Extract of Holarrhena floribunda (G. Don) Durand and Schinz Leaves in Wistar Rats, Sch. Acad. J. Pharm, vol.6, issue.6, pp.229-235, 2017.

, Ligne directrice de l'OCDE pour les essais de produits chimiques, Toxicité orale à dose répétées-rongeurs: 90 jours. OCDE 408, 1998.

W. T. Friedwald, R. I. Levy, and D. S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, vol.18, pp.499-502, 1972.

A. D. Wallace, S. A. Meyer, and . Hepatotoxicity, A Textbook of Modern toxicology. 4 th, pp.277-290, 2010.

J. T. Mukinda and J. A. Syce, Acute and chronic toxicity of the aqueous extract of Artemisia afra in rodents, J. Ehtnopharmacol, vol.112, issue.1, pp.138-144, 2007.

B. M. Gomé, K. Koffi, A. Touré, and F. Traoré, Étude de la toxicité aiguë et subchronique de l'extrait aqueux de Passiflora foetida Linn. (Passifloraceae) chez les rats et les souris, Int. J. Biol. Chem. Sci, vol.5, issue.5, pp.1777-1789, 2011.

I. L. Kamo, T. Bi, I. O. Gnahoue, G. Kra, A. K. Djaman et al., Hepatic tolerance study of hydro-alcoholic extract of Terminalia mantaly H. Perrier (Combretaceae) in rats, The Journal of Phytopharmacology, vol.4, issue.3, pp.164-171, 2015.

A. Akhtar, A. A. Deshmukh, C. G. Raut, A. P. Somkuwar, and S. S. Bhagat, Prallethrin induced serum biochemical changes in Wistar rats, Pesticide Biochemistry and Physiology, vol.102, pp.160-168, 2012.

D. Boussarie, Consultation des petits mammifères de compagnie, Editions du Point Vétérinaire, vol.218, 2003.

P. Alexandre, Cytologie hépatique (augmentation des aminotransférases chez l'adulte, Hépato Gastro, vol.20, pp.630-639, 2013.

O. Coatmeur, M. Latournerie, and P. Hillon, Thérapeutique chezles patients atteints de maladiedu foie, Médecine thérapeutique, vol.10, issue.1, pp.34-42, 2007.

I. Funke and M. F. Melzig, Traditionally used plants in diabetes therapy phytotherapeutics as inhibitors of ?-amylase activity, Brazilian Journal of Pharmacognosy, vol.16, issue.1, pp.1-5, 2006.

J. Cuihua, W. Qingqing, W. Yujian, Y. Nan, W. Zhengfeng et al., Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice, Journal of Ethnopharmacology, vol.176, pp.17-26, 2015.

K. A. Mahdy, A. Wonnerth, K. Huber, and J. Wojta, Cardiovascular disease risk reduction by raising HDL cholesterol -current therapies and future opportunities, British Journal of Pharmacology, vol.167, pp.1177-1194, 2012.

. How, D. D. Koudou, I. O. Tra-bi, Y. E. Kouadio, A. P. Yapo et al., Hepatic tolerance of an ethyl acetate extract of Holarrhena floribunda (G. Don) Durand and Schinz leaves in Wistar Rats, J Phytopharmacol, 2017.